Epigenic Therapeutics

Bioscience & Disease Healthcare Systems Deep Tech

Bioscience & Disease Healthcare Systems +1

Website LinkedIn Shanghai , Shanghai , China

About Epigenic Therapeutics

A clinical-stage innovative drug development company focused on next-generation gene modulation therapy utilizing regulation of epigenetic mechanisms to treat various diseases.

Business Information

Target Customers

pharmaceutical companies research institutions healthcare providers

Industry Categories

Bioscience & Disease Healthcare Systems Deep Tech

Business Model

Revenue Model B2B partnerships and collaborations

Pricing Strategy Negotiated based on partnership agreements

Sales Channels direct sales, partnerships

Funding Timeline

Round	Date	Amount	Investors
Series B	Oct 10, 2023	$60.0M	Lapam Investment, Qiming Venture Partners, OrbiMed

Founders

No founder information available.

Investors

Recent Mentions

Minhua Chu @chuminhua432

Sep 08, 2025

🇨🇳 #Epigenic Therapeutics, a clinical-stage innovative drug development company, today announced the completion of a $60 million Series B round of #financing led by Lapam Capital, with continued participation from existing investors Qiming Venture Partners and OrbiMed, and https://t.co/rkTsZyK2Gr

View on Twitter

Raising.fi @raisingfi

Sep 08, 2025

New Raise 🏛️ Company: Epigenic Therapeutics 🔗 Website: https://t.co/6ZOE5eABCQ 📊 Amount: $60 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: Biotechnology

View on Twitter